Does Cardiac Contractility Modulation Therapy Reduce Atrial Fibrillation Burden?

Cardiac contractility modulation (CCM) is an implantable technology approved by the U.S. Food and Drug Administration and intended for heart failure patients without a cardiac resynchronization therapy indication. CCM leads to reduced heart failure hospitalizations and improvements in exercise toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jae Wook, Atoot, Rami, Heyer, Marissa, Jamal, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635568/
https://www.ncbi.nlm.nih.gov/pubmed/36605296
http://dx.doi.org/10.19102/icrm.2022.13104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635568/
https://www.ncbi.nlm.nih.gov/pubmed/36605296
http://dx.doi.org/10.19102/icrm.2022.13104

Ejemplares similares